Sotac Pharmaceuticals Ltd - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

8.05

2.30

2.30

2.30

Share application money

9.47

-

-

-

Preference share capital

-

-

-

-

Reserves & surplus

3.47

4.32

1.92

1.07

Loan funds

Secured loans

10.66

7.39

6.68

7.20

Unsecured loans

-

-

-

-

Total

31.65

14.01

10.90

10.57

Uses of funds

Fixed assets

Gross block

17.95

13.54

10.04

8.91

Less : revaluation reserve

-

-

-

-

Less : accumulated depreciation

3.86

4.74

3.62

2.50

Net block

14.09

8.80

6.42

6.41

Capital work-in-progress

0.04

-

-

-

Investments

4.00

0.39

2.34

2.20

Net current assets

Current assets, loans & advances

36.65

26.06

13.15

12.60

Less : current liabilities & provisions

23.13

21.24

11.01

10.64

Total net current assets

13.52

4.82

2.14

1.96

Miscellaneous expenses not written

-

-

-

-

Total

31.65

14.01

10.90

10.57

Notes:

Book value of unquoted investments

4.00

0.39

2.34

2.20

Market value of quoted investments

-

-

-

-

Contingent liabilities

-

0.40

-

-

Number of equity sharesoutstanding (Lacs)

80.50

23.00

23.00

23.00